This study is testing a new, non-invasive headband called ATTN201 for people with Obsessive Compulsive Disorder (OCD). The headband uses low-intensity focused ultrasound (LIFU) to target a specific area of the brain (the subthalamic nucleus or STN) that may be involved in OCD symptoms. We are looking for about 40 participants, aged 22 to 80, who have been diagnosed with OCD for over a year and have a Y-BOCS score (a measure of OCD severity) above 16. If you are on OCD medication, your dose must be stable for at least three weeks before joining and throughout the study. The main goals are to see how much OCD symptoms change and to track any side effects over three months. The study status is currently unclear.

Study design

This is a randomized, double-blind study with 40 participants. Half will receive the active ATTN201 device, and half will receive a sham (inactive) device.

What's involved

Participation lasts about 12 to 16 weeks and involves 14 in-person and remote visits.

Compensation

Not stated in the trial record.

Follow-up

Participants will be followed for changes in OCD symptoms and adverse events for up to 3 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.